سعر سبازموبيرالجين-ام 25*10 اقراص 2024

Spasmopyralgin-m 25*10 tablets (Kahira, Egypt): oral tablets combining camylofin (antispasmodic) and metamizole/dipyrone (analgin, pyrazolone analgesic-antipyretic).

• Biliary, renal and intestinal colics; dysmenorrhoea and cervical spasm; as antipyretic; pains due to pancreatitis.Population: Adults; children 10-12 years

• Metamizole must not be used in patients with a previous metamizole- or other pyrazolone/pyrazolidine-induced agranulocytosis, impaired bone marrow function or diseases of the haematopoietic system.General active-ingredient information · European Medicines Agency (EMA)

• Agranulocytosis (possibly fatal) can occur at any time during or shortly after metamizole treatment, independent of dose and even after previous uneventful use. Patients must stop treatment and seek immediate medical attention for fever, chills, sore throat or painful mucosal sores; symptoms may be masked when taken for fever or with antibiotics.General active-ingredient information · European Medicines Agency (EMA)

English text not available for this section.